Nephrocare Health Revenue Jumps 32% to ₹999 Cr in FY26, Profit Soars 74%

HEALTHCAREBIOTECH
Whalesbook Corporate News Logo
AuthorAnanya Iyer|Published at:
Nephrocare Health Revenue Jumps 32% to ₹999 Cr in FY26, Profit Soars 74%
Overview

Nephrocare Health Services announced strong financial results for FY26, with revenue climbing 32.2% to ₹998.8 crore. The company also saw its Adjusted Profit After Tax (PAT) surge by 74.6% to ₹128.3 crore, highlighting efficient scaling and operational leverage.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • ✓Quarterly Results
  • ✓Concall Announcements
  • ✓New Orders & Big Deals
  • ✓Capex Announcements
  • ✓Bulk Deals
  • ✦And much more
Add StocksGet it on Google PlayDownload on the App Store

Nephrocare Health Services Reports Strong FY26 Financials

Nephrocare Health Services announced its financial results for the fiscal year 2026, revealing significant growth. The company achieved a total revenue of ₹998.8 crore, marking a substantial 32.2% increase compared to the previous year.

Profitability also saw a major boost, with Adjusted Profit After Tax (PAT) rising by 74.6% to ₹128.3 crore. This performance indicates that Nephrocare Health Services has effectively scaled its operations and benefited from strong operational leverage.

Key factors driving this performance include the company's expanding platform and strategic initiatives. Investors will be closely watching the progress of its expansion in Saudi Arabia and the renewal of Public-Private Partnership (PPP) agreements.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Add Stocks
Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.